Patents for A61P 19 - Drugs for skeletal disorders (81,981)
05/2002
05/23/2002WO2001092253A3 Inhibitors of alpha l beta 2 mediated cell adhesion
05/23/2002WO2001089494A3 Use of zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases
05/23/2002WO2001083479A3 Process for the preparation of pyrazolopyridine derivatives
05/23/2002WO2001081340A3 Heterocycles that are inhibitors of impdh enzyme
05/23/2002WO2001079444A3 Albumin fusion proteins
05/23/2002WO2001079164A3 N-substituted dithiocarbamates for the treatment of biological disorders
05/23/2002WO2001074344A3 Small organic molecule regulators of cell proliferation
05/23/2002WO2001072826A3 Oncogenic osteomalacia-related gene 1
05/23/2002WO2001072707A3 Carbamate caspase inhibitors and uses thereof
05/23/2002WO2001068866A3 Estrogen-regulated unconventional myosin-related protein: compositions and methods of use
05/23/2002WO2001047946A9 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR
05/23/2002WO2001041760A9 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
05/23/2002WO2000063204A3 Substituted azoles
05/23/2002US20020062031 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
05/23/2002US20020062008 Novel human beta2 integrin alpha subunit
05/23/2002US20020061923 Diacid isoindoleine amide derivative
05/23/2002US20020061920 Selected fused pyrrolocarbazoles
05/23/2002US20020061914 Benzothiazole, benzooxazole and benzoimidazole derivatives as sodium or calcium channel modulators
05/23/2002US20020061911 Enantiomers of 6-amino EM-12 and method of use
05/23/2002US20020061904 Hydroxyesters of 7-desmethylrapamycin
05/23/2002US20020061878 Diazacycloalkanedione derivatives
05/23/2002US20020061877 Substituted cyclic amine metalloprotease inhibitors
05/23/2002US20020061866 Pharmaceutical compositions comprising in combination a bisphosphonate and a matrix metalloproteinase inhibitor
05/23/2002US20020061853 Caspase inhibtors and uses thereof
05/23/2002US20020061846 Administering to a mammal Group B- beta hemolytic streptococci(GBS) toxin receptors or immunogenic fragments to induce an immune response to the GBS receptors for prventing pathoangiogenic conditions
05/23/2002US20020061844 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt
05/23/2002US20020061834 Human G-protein Chemokine receptor (CCR5) HDGNR10
05/23/2002CA2763223A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
05/23/2002CA2429897A1 M. tuberculosis chaperonin 10 and uses thereof
05/23/2002CA2429894A1 M. tuberculosis chaperonin 60.1 and uses thereof
05/23/2002CA2429628A1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
05/23/2002CA2429455A1 Fat regulated genes, uses thereof, and compounds for modulating same
05/23/2002CA2429195A1 Immunoglobulin superfamily proteins
05/23/2002CA2428709A1 Association of calpain inhibitors and reactive oxygen species trapping agents
05/23/2002CA2428647A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
05/23/2002CA2428527A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors
05/23/2002CA2428519A1 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
05/23/2002CA2425117A1 Dibenzoxazepine alpha v integrin receptor antagonist
05/22/2002EP1206573A1 26 human secreted proteins
05/22/2002EP1206553A2 Isomerase proteins
05/22/2002EP1206541A1 Dendritic enriched secreted lymphocyte activation molecule
05/22/2002EP1206527A1 Treatment of inflammatory or malignant disease using dnazymes
05/22/2002EP1206485A2 New effectors of dipeptidyl peptidase iv for topical use
05/22/2002EP1206480A2 Methods of obtaining 2-methoxyestradiol of high purity
05/22/2002EP1206474A1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors
05/22/2002EP1206467A1 N-heterocyclic derivatives as nos inhibitors
05/22/2002EP1206462A2 Heterocyclic compounds inhibiting angiogenesis
05/22/2002EP1206455A1 ALPHAvBETA3 INTEGRIN INHIBITORS
05/22/2002EP1206454A1 NOVEL INTEGRIN ALPHAvBETA3 INHIBITORS
05/22/2002EP1206448A1 Novel vitamin d analogues
05/22/2002EP1206444A1 Compounds that inhibit tryptase activity
05/22/2002EP1206265A1 Src kinase inhibitor compounds
05/22/2002EP1206260A1 Src kinase inhibitor compounds
05/22/2002EP1169326A4 Process for preparing alendronic acid
05/22/2002EP0894093B1 Soluble tachykinin antagonists, the preparation and use thereof
05/22/2002CN1350539A Imidazo-containing heterocyclic compounds, their compositions and uses
05/22/2002CN1350537A Cyclic substituted fused pyrrolocarbazoles and isoindolones
05/22/2002CN1350530A 酰胺衍生物 Amide derivatives
05/22/2002CN1350458A Protease inhibitors
05/22/2002CN1349983A Non-peptide neomatal vascularization inhibitor
05/22/2002CN1349822A Wind-evil dispelling medicine
05/22/2002CN1085205C Bicyclic amino acids
05/22/2002CN1085089C Medicine for curing sciatica
05/22/2002CN1085085C Chinese drug for curing rheumatism and its producing technology
05/21/2002US6392053 Process for preparing arylacetylaminothiazoles
05/21/2002US6391920 Administering hormone inhibitor; stimulant of testosterone
05/21/2002US6391917 Analgesic
05/21/2002US6391908 Oxime amide indole type sPLA2 inhibitors
05/21/2002US6391904 Bone disorders
05/21/2002US6391887 3,4-Dihydroquinoline derivatives as nitrogen monoxide synthase (NOS) inhibitors
05/21/2002US6391864 Glucosamine mixtures
05/21/2002US6391856 Method for treatment of allergic reaction using formyl peptide
05/21/2002US6391588 Nucleotides squences coding preferential amino acid sequences for use in treating bone disorder in mammals
05/21/2002US6391309 Composition made from plant matter enriched in at least two phytochemicals selected from isoflavones, lignans, saponins, sapogenins, catechins and phenolic acids; therapeutic treatment for female disorders
05/21/2002US6391308 Method of preparing and using isoflavones for the treatment of blood related illnesses
05/21/2002US6391297 Differentiation of adipose stromal cells into osteoblasts and uses thereof
05/21/2002CA2223245C Catechol diethers derivatives useful as pharmaceutical agents
05/16/2002WO2002038797A2 Modulators of bruton's tyrosine kinase, their identification and use
05/16/2002WO2002038775A2 METHODS FOR PRODUCING AND PURIFYING RECOMBINANT α-L-IDURONIDASE
05/16/2002WO2002038764A2 Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage
05/16/2002WO2002038575A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
05/16/2002WO2002038563A2 Condensed pyrazindione derivatives as pde inhibitors
05/16/2002WO2002038561A1 Indolylmaleimide derivatives as protein kinase c inhibitors
05/16/2002WO2002038551A1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands
05/16/2002WO2002038548A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
05/16/2002WO2002038171A2 METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE
05/16/2002WO2002038169A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
05/16/2002WO2002038140A2 Therapeutic uses for ip3 receptor-mediated calcium channel modulators
05/16/2002WO2002038106A2 Calcilytic compounds
05/16/2002WO2002020488A3 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor
05/16/2002WO2002019994A3 The treatment of inflammatory disorders
05/16/2002WO2002017892A3 Water-dispersible encapsulated sterols
05/16/2002WO2002002640A3 Antibodies to human mcp-1
05/16/2002WO2002002090A3 Inhibitors of copper-containing amine oxidases
05/16/2002WO2001098291A3 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders
05/16/2002WO2001096295A3 2-cyanopyrrolidine derivatives and their use as medicaments
05/16/2002WO2001083547A3 Anti-inflammatory compounds and uses thereof
05/16/2002WO2001080810A3 Chondroitin synthase gene and methods of making and using same
05/16/2002WO2001076578A8 Treatment of icu-associated hypocalcemia with vitamin d compounds
05/16/2002WO2001075109A3 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability